00:59 Chloroquine on rocky groundPresident Trump's preferred coronavirus treatment is the focus of a new study suggesting it could cause more harm than good, but not everybody agrees. We discuss the fallout as trials around the world are paused and countries diverge over policy advice.News: India expands use of controversial coronavirus drug amid safety concernsNews: Safety fears over hyped drug hydroxychloroquine spark global confusion12:12 Are we rushing science?Coronavirus papers are being published extremely quickly, while normally healthy scientific debate is being blown up in the world’s press. Is there a balancing act between timely research and accurate messaging?18:49 One good thingOur hosts pick out things that have made them smile in the last week, including hedgerow brews and a trip into the past using AI.Recipe: Elderflower 'Champagne'Video: Denis Shiryaev restores historic footage with AI22:30 The latest coronavirus research papersNoah Baker takes a look through some of the key coronavirus papers of the last few weeks.News: Coronavirus research updatesmedRxiv: Full genome viral sequences inform patterns of SARS-CoV-2 spread into and within IsraelHarvard Library: Reductions in commuting mobility predict geographic differences in SARS-CoV-2 prevalence in New York CityScience: DNA vaccine protection against SARS-CoV-2 in rhesus macaques Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.